Background
Periodontitis is a chronic multifactorial inflammatory disease.
Porphyromonas gingivalis
is a primary periopathogen in the initiation and development of periodontal disease. Evidence has shown that
P. gingivalis
is associated with systemic diseases, including IBD and fatty liver disease. Inflammatory response is a key feature of diseases related to this species.
Methods
C57BL/6 mice were administered either PBS, or
P. gingivalis
. After 9 weeks, the inflammatory response in gut, spleen, and liver was analyzed.
Results
The findings revealed significant disturbance of the intestinal microbiota and increased inflammatory factors in the gut of
P. gingivalis
-administered mice. Administrated
P. gingivalis
remarkably promoted the secretion of IRF-1 and activated the inflammatory pathway IFN-γ/STAT1 in the spleen. Histologically, mice treated with
P. gingivalis
exhibited hepatocyte damage and lipid deposition. The inflammatory factors IL-17a, IL-6, and ROR-γt were also upregulated in the liver of mice fed with
P. gingivalis
. Lee’s index, spleen index, and liver index were also increased.
Conclusion
These results suggest that administrated
P. gingivalis
evokes inflammation in gut, spleen, and liver, which might promote the progression of various systemic diseases.